Megna Michael R
CHIEF ACCOUNTING OFFICER · 26 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-04-09 | KNSA | Kiniksa Pharmaceuticals International, plc | Sale | 6,625 | $46.69 | $309,321.25 | filing |
| 2026-04-07 | KNSA | Kiniksa Pharmaceuticals International, plc | Tax withholding | 1,666 | $48.94 | $81,534.04 | filing |
| 2026-04-07 | KNSA | Kiniksa Pharmaceuticals International, plc | Option exercise | 3,932 | $1.00 | $3,932.00 | filing |
| 2026-04-01 | KNSA | Kiniksa Pharmaceuticals International, plc | Tax withholding | 3,205 | $48.13 | $154,256.65 | filing |
| 2026-04-01 | KNSA | Kiniksa Pharmaceuticals International, plc | Option exercise | 7,564 | — | — | filing |
| 2026-01-15 | KNSA | Kiniksa Pharmaceuticals International, plc | Award | 372 | $24.16 | $8,987.52 | filing |
| 2025-10-20 | KNSA | Kiniksa Pharmaceuticals International, plc | Sale | 37,255 | $38.72 | $1.4M | filing |
| 2025-10-20 | KNSA | Kiniksa Pharmaceuticals International, plc | Sale | 13,235 | $39.31 | $520,267.85 | filing |
| 2025-10-20 | KNSA | Kiniksa Pharmaceuticals International, plc | Option exercise | 12,787 | $10.76 | $137,588.12 | filing |
| 2025-10-20 | KNSA | Kiniksa Pharmaceuticals International, plc | Option exercise | 9,831 | $11.97 | $117,677.07 | filing |
| 2025-10-20 | KNSA | Kiniksa Pharmaceuticals International, plc | Option exercise | 9,831 | $11.10 | $109,124.10 | filing |
| 2025-10-20 | KNSA | Kiniksa Pharmaceuticals International, plc | Option exercise | 6,195 | $12.97 | $80,349.15 | filing |
| 2025-10-20 | KNSA | Kiniksa Pharmaceuticals International, plc | Option exercise | 791 | $15.50 | $12,260.50 | filing |
| 2025-10-04 | KNSA | Kiniksa Pharmaceuticals International, plc | Tax withholding | 85 | $38.49 | $3,271.65 | filing |
| 2025-10-04 | KNSA | Kiniksa Pharmaceuticals International, plc | Option exercise | 175 | — | — | filing |
| 2025-09-03 | KNSA | Kiniksa Pharmaceuticals International, plc | Sale | 11,000 | $34.84 | $383,240.00 | filing |
| 2025-09-03 | KNSA | Kiniksa Pharmaceuticals International, plc | Option exercise | 11,000 | $17.92 | $197,120.00 | filing |
| 2025-09-02 | KNSA | Kiniksa Pharmaceuticals International, plc | Tax withholding | 375 | $34.28 | $12,855.00 | filing |
| 2025-09-02 | KNSA | Kiniksa Pharmaceuticals International, plc | Option exercise | 774 | — | — | filing |
| 2025-09-01 | KNSA | Kiniksa Pharmaceuticals International, plc | Tax withholding | 4,282 | $33.49 | $143,404.18 | filing |
| 2025-09-01 | KNSA | Kiniksa Pharmaceuticals International, plc | Option exercise | 2,557 | — | — | filing |
| 2025-09-01 | KNSA | Kiniksa Pharmaceuticals International, plc | Option exercise | 2,363 | — | — | filing |
| 2025-09-01 | KNSA | Kiniksa Pharmaceuticals International, plc | Option exercise | 3,933 | — | — | filing |
| 2025-08-04 | KNSA | Kiniksa Pharmaceuticals International, plc | Sale | 17,000 | $32.35 | $549,950.00 | filing |
| 2025-08-04 | KNSA | Kiniksa Pharmaceuticals International, plc | Option exercise | 17,000 | $15.52 | $263,840.00 | filing |
| 2025-07-15 | KNSA | Kiniksa Pharmaceuticals International, plc | Award | 495 | $15.63 | $7,736.85 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.